Hjem › Lymfom › Ohio › Cleveland
Lymfom kliniske forsøg i Cleveland, OH
14 studier for Lymfom søger deltagere på steder i og omkring Cleveland (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
RekruttererFase 1/2
- University Hospitals Seidman Cancer Center, Cleveland
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
RekruttererFase 1
- University Hospitals Cleveland Medical Center, Cleveland
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
RekruttererFase 2
- Cleveland Clinic, Cleveland
A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy
RekruttererFase 2
- University Hospitals Cleveland Medical Center, Cleveland
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
RekruttererFase 2
- The Cleveland Clinic Foundation, Cleveland
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
RekruttererFase 3
- Research Site, Cleveland
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RekruttererFase 1/2
- Cleveland Clinic, Cleveland
A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
RekruttererFase 1/2
- Cleveland Clinic, Cleveland
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
RekruttererFase 3
- Cleveland Clinical Taussig Cancer Center, Cleveland
A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)
RekruttererFase 1
- University Hospitals Cleveland Medical Center, Cleveland
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
RekruttererFase 1
- Cleveland Clinic, Cleveland
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
RekruttererFase 1/2
- Cleveland Clinic, Cleveland
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
- Cleveland Clinic, Cleveland
Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma
RekruttererFase 1
- Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland
Lymfom forsøg i andre byer
- Houston, TX34 studier
- Boston, MA33 studier
- New York City, NY33 studier
- Washington, DC23 studier
- Baldwin Park, CA21 studier
- Chicago, IL20 studier
- Durham, NC17 studier
- St. Louis, MO15 studier
- Philadelphia, PA15 studier
- Edison, NJ12 studier
- Atlanta, GA12 studier
- Seattle, WA12 studier
Andre studier i Cleveland
- Ikke-småcellet lungecancer43 studier
- Kræft (alle typer)36 studier
- Brystkræft35 studier
- Prostatakræft34 studier
- Hjertesvigt33 studier
- Metastatisk cancer30 studier
- Ægstockræft30 studier
- Lungecancer26 studier
- Colorektal kræft24 studier
- Kardiovaskulær sygdom22 studier
- Livmoderslimhindekræft20 studier
- Akut myeloid leukæmi20 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.